Shopping Cart
- Remove All
- Your shopping cart is currently empty
CB 300919 is a quinazoline-based antitumor agent exhibiting high activity against CH1 human ovarian tumor xenografts, with continuous exposure (96 h) resulting in a growth inhibition (IC50: 2 nM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | Inquiry | 3-6 months | |
50 mg | Inquiry | 3-6 months | |
100 mg | Inquiry | 3-6 months |
Description | CB 300919 is a quinazoline-based antitumor agent exhibiting high activity against CH1 human ovarian tumor xenografts, with continuous exposure (96 h) resulting in a growth inhibition (IC50: 2 nM). |
Molecular Weight | 584.11 |
Formula | C32H34ClN7O2 |
Cas No. | 289715-28-2 |
Relative Density. | 1.26 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (171.2 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.